117 related articles for article (PubMed ID: 3322403)
1. Kinetics of the inhibition of human renin by an inhibitor containing a hydroxyethylene dipeptide isostere.
Kati WM; Pals DT; Thaisrivongs S
Biochemistry; 1987 Dec; 26(24):7621-6. PubMed ID: 3322403
[TBL] [Abstract][Full Text] [Related]
2. alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
Thaisrivongs S; Pals DT; Lawson JA; Turner SR; Harris DW
J Med Chem; 1987 Mar; 30(3):536-41. PubMed ID: 3546690
[TBL] [Abstract][Full Text] [Related]
3. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
4. An orally active inhibitor of renin.
Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
6. On the specificity of human renin. Studies with peptide inhibitors.
Poulsen K; Haber E; Burton J
Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126
[TBL] [Abstract][Full Text] [Related]
7. Interaction of mouse submaxillary gland renin with a statine-containing, subnanomolar, competitive inhibitor.
Poe M; Perlow DS; Boger J
J Enzyme Inhib; 1985; 1(1):13-23. PubMed ID: 3916910
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
Johnson RL; Verschoor K
J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
[TBL] [Abstract][Full Text] [Related]
9. Comparison of angiotensinogen and tetradecapeptide as substrates for human renin. Substrate dependence of the mode of inhibition of renin by a statine-containing hexapeptide.
Stammers DK; Dann JG; Harris CJ; Smith DR
Arch Biochem Biophys; 1987 Nov; 258(2):413-20. PubMed ID: 3314712
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
11. N-(alpha-Hydroxyalkanoyl) derivatives of Leu-Val-Phe-OCH3 as inhibitors of renin.
Johnson RL
J Med Chem; 1980 Jun; 23(6):666-9. PubMed ID: 6993683
[TBL] [Abstract][Full Text] [Related]
12. Purification of hog renin by affinity chromatography using the synthetic competitive inhibitor (D-Leu6)octapeptide.
Poulsen K; Burton J; Haber E
Biochim Biophys Acta; 1975 Aug; 400(2):258-62. PubMed ID: 240415
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a potent inhibitor of subprimate and primate renins.
Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
[TBL] [Abstract][Full Text] [Related]
14. Statine-containing dipeptide and tripeptide inhibitors of human renin.
Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of a renin inhibitor in relation to posture in nonhuman primates.
Pals DT; DeGraaf GL; Kati WM; Lawson JA; Smith CW; Skala GF
Clin Exp Hypertens A; 1985; 7(1):105-21. PubMed ID: 2986882
[TBL] [Abstract][Full Text] [Related]
17. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
18. Competitive inhibitors of renin. Inhibitors effective at physiological pH.
Burton J; Poulsen K; Haber E
Biochemistry; 1975 Aug; 14(17):3892-8. PubMed ID: 240395
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human renin by synthetic peptides derived from its prosegment.
Cumin F; Evin G; Fehrentz JA; Seyer R; Castro B; Menard J; Corvol P
J Biol Chem; 1985 Aug; 260(16):9154-7. PubMed ID: 3894354
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of renin by substrate analogue inhibitors containing the olefinic amino acid 5(S)-amino-7-methyl-3(E)-octenoic acid.
Johnson RL
J Med Chem; 1984 Oct; 27(10):1351-4. PubMed ID: 6384520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
